Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 2, 2011, Pages 257-264

  Moe, Sharon M ^a,b   Zidehsarai, Miriam P ^a   Chambers, Mary A ^a   Jackman, Lisa A ^c   Radcliffe, J Scott ^c   Trevino, Laurie L ^a   Donahue, Susan E ^d   Asplin, John R ^d  

^a INDIANA UNIVERSITY   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PURDUE UNIVERSITY   (United States)

^d LithoLink Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DIETARY INTAKE; DIURNAL ANIMAL; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; MALE; MEAT; PHOSPHATE BLOOD LEVEL; PROTEIN INTAKE; URINARY EXCRETION; VEGETARIAN DIET;

AGED; BIOLOGICAL MARKERS; CALCIUM; CHRONIC DISEASE; CROSS-OVER STUDIES; DIET, VEGETARIAN; DIETARY PROTEINS; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HOMEOSTASIS; HUMANS; INDIANA; KIDNEY DISEASES; LINEAR MODELS; MALE; MEAT; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS, DIETARY; PLANT PROTEINS; TIME FACTORS;

EID: 79951895648     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05040610     Document Type: Article

References (35)

1. Bricker NS: On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". N Engl J Med 286: 1093-1099, 1972
2. Nagano N, Miyata S, Abe M, Kobayashi N, Wakita S, Yamashita T, Wada M: Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats. Kidney Int 69: 531-537, 2006 (Pubitemid 43164446)
3. Moe SM: Current issues in the management of secondary hyperparathyroidism and bone disease. Perit Dial Int 21[Suppl 3]: S241-S246, 2001
4. Kidney Disease Outcomes Quality Initiative, National Kidney Foundation: Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis 42: S1-S201, 2003
5. Kyriazis J, Stamatiadis D, Mamouna A: Intradialytic and interdialytic effects of treatment with 1.25 and 1. 75 Mmol/L of calcium dialysate on arterial compliance in patients on hemodialysis. Am J Kidney Dis 35: 1096-1103, 2000 (Pubitemid 30354413)
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guidelines for the management of CKD-MBD. Kidney Int Suppl 76: S1-S130, 2009
7. Edmonds ME, Morrison N, Laws JW, Watkins PJ: Medial arterial calcification and diabetic neuropathy. BMJ (Clin Res Ed) 284: 928-930, 1982 (Pubitemid 12192941)
8. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone VH II: A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 75: 176-184, 2009
9. Wheeler ML, Fineberg SE, Fineberg NS, Gibson RG, Hackward LL: Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria: Effects on renal, glycemic, and lipid parameters. Diabetes Care 25: 1277-1282, 2002 (Pubitemid 41071132)
10. Portale AA, Booth BE, Halloran BP, Morris RC Jr: Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest 73: 1580-1589, 1984 (Pubitemid 14084474)
11. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, Marbury M, Sehgal AR: Effect of food additives on hyperphosphatemia among patients with endstage renal disease: A randomized controlled trial. JAMA 301: 629-635, 2009
12. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW Jr: Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134: 1874-1880, 2004
13. Azadbakht L, Esmaillzadeh A: Soy-protein consumption and kidney-related biomarkers among type 2 diabetics: A crossover, randomized clinical trial. J Ren Nutr 19: 479-486, 2009
14. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB: Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64: 2272-2279, 2003 (Pubitemid 37449564)
15. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor- 23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16: 2205-2215, 2005 (Pubitemid 41716454)
16. Wolf M: Fibroblast growth factor 23 and the future of phosphorus management. Curr Opin Nephrol Hypertens 18: 463-468, 2009
17. Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, Shuto E, Nashiki K, Arai H, Yamamoto H, Takeda E: Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70: 2141-2147, 2006 (Pubitemid 44871378)
18. Ferrari SL, Bonjour JP, Rizzoli R: Fibroblast growth factor- 23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90: 1519-1524, 2005 (Pubitemid 40464013)
19. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS: Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 21: 1187-1196, 2006 (Pubitemid 44128331)
20. Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M: Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol, 19: 615-623, 2008 (Pubitemid 351355405)
21. Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moyses RM: Early control of PTH and FGF23 in normophosphatemic CKD patients: A new target in CKD-MBD therapy? Clin J Am Soc Nephrol 5: 286-291, 2010
22. Portale AA, Halloran BP, Morris RC, Jr: Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest 80: 1147-1154, 1987 (Pubitemid 18075654)
23. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL: Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol 292: F66-F75, 2007 (Pubitemid 46105244)
24. Trivedi H, Moore H, Atalla J: Lack of significant circadian and post-prandial variation in phosphate levels in subjects receiving chronic hemodialysis therapy. J Nephrol 18: 417-422, 2005 (Pubitemid 41700105)
25. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218, 2004 (Pubitemid 39031360)
26. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67: 1179-1187, 2005 (Pubitemid 41623345)
27. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL: Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16: 520-528, 2005 (Pubitemid 41725150)
28. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633, 2005 (Pubitemid 41532599)
29. Narang R, Ridout D, Nonis C, Kooner JS: Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60: 73-79, 1997 (Pubitemid 27288259)
30. Goransson LG, Skadberg O, Bergrem H: Albumin-corrected or ionized calcium in renal failure? What to measure? Nephrol Dial Transplant 20: 2126-2129, 2005 (Pubitemid 41510087)
31. Shields JB, Fairbands BW, Berryman GH, Mitchell HH: The utilization of calcium in carrots, lettuce and string beans in comparison with the calcium in milk. J Nutr 20, 1940
32. Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerstrom G, Jonsson KB, Westin G, Larsson TE: Fibroblast growth factor-23 regulates parathyroid hormone and 1α-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195: 125-131, 2007 (Pubitemid 350056006)
33. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J: The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117: 4003-4008, 2007 (Pubitemid 350224109)
34. Canalejo R, Canalejo A, Martinez-Moreno JM, Rodriguez-Ortiz ME, Estepa JC, Mendoza FJ, Munoz- Castaneda JR, Shalhoub V, Almaden Y, Rodriguez M: FGF23 fails to inhibit uremic parathyroid glands. J Am Soc Nephrol 21: 1125-1135, 2010
35. Sherman RA, Mehta O: Dietary phosphorus restriction in dialysis patients: Potential impact of processed meat, poultry, and fish products as protein sources. Am J Kidney Dis 54: 18-23, 2009